<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>

<PubmedArticle>
<MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">7349888</PMID>
    <DateCompleted>
        <Year>1980</Year>
        <Month>02</Month>
        <Day>26</Day>
    </DateCompleted>
    <DateRevised>
        <Year>2011</Year>
        <Month>04</Month>
        <Day>28</Day>
    </DateRevised>
    <Article PubModel="Print">
        <Journal>
            <ISSN IssnType="Print">0008-5472</ISSN>
            <JournalIssue CitedMedium="Print">
                <Volume>40</Volume>
                <Issue>1</Issue>
                <PubDate>
                    <Year>1980</Year>
                    <Month>Jan</Month>
                </PubDate>
            </JournalIssue>
            <Title>Cancer research</Title>
            <ISOAbbreviation>Cancer Res</ISOAbbreviation>
        </Journal>
        <ArticleTitle>An evaluation of chemicals and industrial processes associated with cancer in humans based on human and animal data: IARC Monographs Volumes 1 to 20.</ArticleTitle>
        <Pagination>
            <MedlinePgn>1-12</MedlinePgn>
        </Pagination>
        <Abstract>
            <AbstractText>An international ad hoc Working Group of experts in cancer research met at the International Agency for Research on Cancer (IARC) in January 1979 to evaluate the data on human and experimental animal carcinogenicity for 54 chemicals, groups of chemicals, and industrial processes. Monographs for these chemicals were published in Vols. 1 to 20 of the IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans. Based on evidence from human studies, 18 of the 54 chemicals or industrial processes are human carcinogens. A further 18 chemicals are probably carcinogenic for humans, although the data were considered not adequate to establish a causal association. To reflect differing degrees of evidence of carcinogenicity within this group, the chemicals were further subdivided, with 6 chemicals exhibiting a high degree of evidence and 12 chemicals exhibiting a lower degree. Data on the remaining 18 chemicals were considered insufficient to allow any evaluation of carcinogenicity. The report summarizes the background, purpose, and overall conclusions of the Working Group. The evidence supporting the evaluations is given in the "Appendix."</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
            <Author ValidYN="Y">
                <CollectiveName Investigators="group-1-7349888.1">Report of an IARC Working Group</CollectiveName>
            </Author>
            <Author ValidYN="Y">
                <LastName>Althouse</LastName>
                <ForeName>R</ForeName>
                <Initials>R</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Huff</LastName>
                <ForeName>J</ForeName>
                <Initials>J</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Tomatis</LastName>
                <ForeName>L</ForeName>
                <Initials>L</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Wllbourn</LastName>
                <ForeName>J</ForeName>
                <Initials>J</Initials>
            </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
            <Grant>
                <GrantID>N01 CP 45608</GrantID>
                <Acronym>CP</Acronym>
                <Agency>NCI NIH HHS</Agency>
                
            </Grant>
        </GrantList>
        <PublicationTypeList>
            <PublicationType UI="D016428">Journal Article</PublicationType>
            <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
        </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cancer Res</MedlineTA>
        <NlmUniqueID>2984705R</NlmUniqueID>
        <ISSNLinking>0008-5472</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
        <Chemical>
            <RegistryNumber>0</RegistryNumber>
            <NameOfSubstance UI="D002274">Carcinogens, Environmental</NameOfSubstance>
        </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
        <MeshHeading>
            <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D002274" MajorTopicYN="N">Carcinogens, Environmental</DescriptorName>
            <QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D004285" MajorTopicYN="N">Dogs</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D004812" MajorTopicYN="N">Epidemiologic Methods</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D007221" MajorTopicYN="Y">Industry</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D007390" MajorTopicYN="N">International Agencies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
            <QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName>
            <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D011817" MajorTopicYN="N">Rabbits</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D012107" MajorTopicYN="N">Research Design</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D012306" MajorTopicYN="N">Risk</DescriptorName>
        </MeshHeading>
    </MeshHeadingList>
    <InvestigatorList ID="group-1-7349888.1">
        <Investigator ValidYN="Y">
            <LastName>Armitage</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Armstrong</LastName>
            <ForeName>B K</ForeName>
            <Initials>BK</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Brown</LastName>
            <ForeName>A L</ForeName>
            <Initials>AL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Bogovski</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Cole</LastName>
            <ForeName>P</ForeName>
            <Initials>P</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Day</LastName>
            <ForeName>N E</ForeName>
            <Initials>NE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Della Porta</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Griesemer</LastName>
            <ForeName>R A</ForeName>
            <Initials>RA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Hirohata</LastName>
            <ForeName>T</ForeName>
            <Initials>T</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Hunter</LastName>
            <ForeName>W J</ForeName>
            <Initials>WJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Jayakar</LastName>
            <ForeName>S D</ForeName>
            <Initials>SD</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Mass√©</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Pike</LastName>
            <ForeName>M C</ForeName>
            <Initials>MC</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Preussemann</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Schneiderman</LastName>
            <ForeName>M A</ForeName>
            <Initials>MA</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Teppo</LastName>
            <ForeName>L</ForeName>
            <Initials>L</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Thomas</LastName>
            <ForeName>D B</ForeName>
            <Initials>DB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Wagoner</LastName>
            <ForeName>J K</ForeName>
            <Initials>JK</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Wald</LastName>
            <ForeName>N J</ForeName>
            <Initials>NJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Weinstein</LastName>
            <ForeName>I B</ForeName>
            <Initials>IB</Initials>
        </Investigator>
    </InvestigatorList>
</MedlineCitation>
<PubmedData>
    <History>
        <PubMedPubDate PubStatus="pubmed">
            <Year>1980</Year>
            <Month>1</Month>
            <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
            <Year>1980</Year>
            <Month>1</Month>
            <Day>1</Day>
            <Hour>0</Hour>
            <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
            <Year>1980</Year>
            <Month>1</Month>
            <Day>1</Day>
            <Hour>0</Hour>
            <Minute>0</Minute>
        </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
        <ArticleId IdType="pubmed">7349888</ArticleId>
    </ArticleIdList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">3154315</PMID>
    <DateCompleted>
        <Year>1991</Year>
        <Month>03</Month>
        <Day>26</Day>
    </DateCompleted>
    <DateRevised>
        <Year>2020</Year>
        <Month>03</Month>
        <Day>04</Day>
    </DateRevised>
    <Article PubModel="Print">
        <Journal>
            <ISSN IssnType="Print">0920-3206</ISSN>
            <JournalIssue CitedMedium="Print">
                <Volume>1</Volume>
                <Issue>2</Issue>
                <PubDate>
                    <Year>1987</Year>
                    <Month>Aug</Month>
                </PubDate>
            </JournalIssue>
            <Title>Cardiovascular drugs and therapy</Title>
            <ISOAbbreviation>Cardiovasc Drugs Ther</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The mortality risk associated with digitalis treatment after myocardial infarction.</ArticleTitle>
        <Pagination>
            <MedlinePgn>125-32</MedlinePgn>
        </Pagination>
        <Abstract>
            <AbstractText>We examined the effects of digitalis therapy on postinfarction mortality throughout a 24-month to 48-month follow-up in 867 patients who survived an acute myocardial infarction. During follow-up, 145 patients died (16.7% mortality). At the time of hospital discharge, 31% of the patients were taking digitalis. The digitalis-treated patients were older, had more medical-cardiac risk factors, and had a higher mortality rate throughout the follow-up than the nondigitalis-treated patients. Statistical techniques were used to adjust for clinical imbalances between the digitalis-treated patients and nondigitalis-treated patients. The survival analysis (n = 728 patients) utilized the Cox regression model, and the digitalis-associated mortality risk was identified only after all significant covariates were allowed, so that mortality could be predicted as accurately as possible. Digitalis therapy was associated with a significantly increased postinfarction mortality risk after adjustment for the predictor covariates (relative risk 2.3, 95% confidence interval 1.4-3.7, p less than 0.001). The findings from this large multicenter study suggest that it would be prudent to exercise caution in the use of digitalis in postinfarction patients.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
            <Author ValidYN="Y">
                <CollectiveName Investigators="group-1-3154315.1">Digitalis Subcommittee of the Multicenter Post-Infarction Research Group</CollectiveName>
            </Author>
            <Author ValidYN="Y">
                <LastName>Moss</LastName>
                <ForeName>A J</ForeName>
                <Initials>AJ</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Bigger</LastName>
                <ForeName>J T</ForeName>
                <Initials>JT</Initials>
                <Suffix>Jr</Suffix>
            </Author>
            <Author ValidYN="Y">
                <LastName>Carleen</LastName>
                <ForeName>E</ForeName>
                <Initials>E</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Fleiss</LastName>
                <ForeName>J L</ForeName>
                <Initials>JL</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Odoroff</LastName>
                <ForeName>C L</ForeName>
                <Initials>CL</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Rolnitzky</LastName>
                <ForeName>L</ForeName>
                <Initials>L</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Therneau</LastName>
                <ForeName>T</ForeName>
                <Initials>T</Initials>
            </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
            <Grant>
                <GrantID>HL 22982</GrantID>
                <Acronym>HL</Acronym>
                <Agency>NHLBI NIH HHS</Agency>
                
            </Grant>
        </GrantList>
        <PublicationTypeList>
            <PublicationType UI="D016430">Clinical Trial</PublicationType>
            <PublicationType UI="D016428">Journal Article</PublicationType>
            <PublicationType UI="D016448">Multicenter Study</PublicationType>
            <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Cardiovasc Drugs Ther</MedlineTA>
        <NlmUniqueID>8712220</NlmUniqueID>
        <ISSNLinking>0920-3206</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
        <Chemical>
            <RegistryNumber>0</RegistryNumber>
            <NameOfSubstance UI="D004071">Digitalis Glycosides</NameOfSubstance>
        </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
        <MeshHeading>
            <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D004071" MajorTopicYN="N">Digitalis Glycosides</DescriptorName>
            <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
            <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D009203" MajorTopicYN="N">Myocardial Infarction</DescriptorName>
            <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
            <QualifierName UI="Q000401" MajorTopicYN="Y">mortality</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
        </MeshHeading>
    </MeshHeadingList>
    <InvestigatorList ID="group-1-3154315.1">
        <Investigator ValidYN="Y">
            <LastName>Moss</LastName>
            <ForeName>A J</ForeName>
            <Initials>AJ</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Bigger</LastName>
            <ForeName>J T</ForeName>
            <Initials>JT</Initials>
            <Suffix>Jr</Suffix>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Case</LastName>
            <ForeName>R B</ForeName>
            <Initials>RB</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Gillespie</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Goldstein</LastName>
            <ForeName>R E</ForeName>
            <Initials>RE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Greenberg</LastName>
            <ForeName>H M</ForeName>
            <Initials>HM</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Krone</LastName>
            <ForeName>R</ForeName>
            <Initials>R</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Marcus</LastName>
            <ForeName>F I</ForeName>
            <Initials>FI</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Odoroff</LastName>
            <ForeName>C L</ForeName>
            <Initials>CL</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Oliver</LastName>
            <ForeName>G C</ForeName>
            <Initials>GC</Initials>
        </Investigator>
    </InvestigatorList>
</MedlineCitation>
<PubmedData>
    <History>
        <PubMedPubDate PubStatus="pubmed">
            <Year>1987</Year>
            <Month>8</Month>
            <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
            <Year>1987</Year>
            <Month>8</Month>
            <Day>1</Day>
            <Hour>0</Hour>
            <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
            <Year>1987</Year>
            <Month>8</Month>
            <Day>1</Day>
            <Hour>0</Hour>
            <Minute>0</Minute>
        </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
        <ArticleId IdType="pubmed">3154315</ArticleId>
        <ArticleId IdType="doi">10.1007/BF02125465</ArticleId>
    </ArticleIdList>
    <ReferenceList>
        <Reference>
            <Citation>Br Heart J. 1962 Nov;24(6):745-60</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">18610183</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Am Coll Cardiol. 1985 Nov;6(5):976-82</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">4045047</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>N Engl J Med. 1983 Aug 11;309(6):331-6</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6866068</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Am Coll Cardiol. 1984 Mar;3(3):681-9</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6693640</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1977 May;55(5):719-27</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">321147</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1984 Feb;69(2):250-8</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6690098</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1983 Apr;67(4):735-42</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6825229</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Stat Med. 1982 Oct-Dec;1(4):353-9</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6764829</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1980 Jul;62(1):17-9</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">7379279</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Acta Med Scand. 1975 Nov;198(5):353-64</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">1199810</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Am J Med. 1979 Jul;67(1):7-14</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">463919</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Am Coll Cardiol. 1984 Oct;4(4):695-702</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6332837</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Electrocardiol. 1969 Jan;2(1):5-9</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">5780211</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1981 Dec;64(6):1150-6</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">7296788</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>N Engl J Med. 1986 Jan 30;314(5):265-71</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">3510391</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Am Coll Cardiol. 1984 Nov;4(5):867-74</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">6491081</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>JAMA. 1966 Sep 5;197(10):775-88</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">5953371</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>J Am Coll Cardiol. 1985 May;5(5 Suppl A):1A-2A</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">3886745</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1973 May;47(5):1076-9</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">4268512</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Am J Cardiol. 1978 Aug;42(2):202-10</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">150785</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Circulation. 1979 Dec;60(6):1252-8</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">498450</ArticleId>
            </ArticleIdList>
        </Reference>
        <Reference>
            <Citation>Am J Cardiol. 1985 Mar 1;55(6):623-30</Citation>
            <ArticleIdList>
                <ArticleId IdType="pubmed">3976501</ArticleId>
            </ArticleIdList>
        </Reference>
    </ReferenceList>
</PubmedData>
</PubmedArticle>
<PubmedArticle>
<MedlineCitation Status="MEDLINE" Owner="NLM">
    <PMID Version="1">8948562</PMID>
    <DateCompleted>
        <Year>1996</Year>
        <Month>12</Month>
        <Day>23</Day>
    </DateCompleted>
    <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>19</Day>
    </DateRevised>
    <Article PubModel="Print">
        <Journal>
            <ISSN IssnType="Print">0028-4793</ISSN>
            <JournalIssue CitedMedium="Print">
                <Volume>335</Volume>
                <Issue>25</Issue>
                <PubDate>
                    <Year>1996</Year>
                    <Month>Dec</Month>
                    <Day>19</Day>
                </PubDate>
            </JournalIssue>
            <Title>The New England journal of medicine</Title>
            <ISOAbbreviation>N Engl J Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The pathophysiology and genetics of congenital lipoid adrenal hyperplasia.</ArticleTitle>
        <Pagination>
            <MedlinePgn>1870-8</MedlinePgn>
        </Pagination>
        <Abstract>
            <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Congenital lipoid adrenal hyperplasia results in severe impairment of steroid biosynthesis in the adrenal glands and gonads that is manifested both in utero and postnatally. We recently found mutations in the gene for the steroidogenic acute regulatory protein in four patients with this syndrome, but it was not clear whether all patients have such mutations or why there is substantial clinical variation in these patients.</AbstractText>
            <AbstractText Label="METHODS" NlmCategory="METHODS">We directly sequenced the gene for steroidogenic acute regulatory protein in 15 patients with congenital lipoid adrenal hyperplasia from 10 countries. Identified mutations were confirmed and recreated in expression vectors, transfected into cultured cells, and assayed for the presence and activity of steroidogenic acute regulatory protein.</AbstractText>
            <AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifteen different mutations in the gene for steroidogenic acute regulatory protein were found in 14 patients; the mutation Gln258Stop was found in 80 percent of affected alleles from Japanese and Korean patients, and the mutation Arg182Leu was found in 78 percent of affected alleles from Palestinian patients. We developed diagnostic tests for these and eight other mutations. Thirteen of the 15 mutations were in exons 5, 6, or 7, and all rendered the steroidogenic acute regulatory protein inactive in functional assays. Some mutants with amino acid replacements were capable of normal mitochondrial processing, indicating that the activity of steroidogenic acute regulatory protein is not associated with its translocation into mitochondria. Steroidogenic cells lacking the protein retained low levels of steroidogenesis. This explains the secretion of some steroid hormones by the ovaries after puberty before affected cells accumulate large amounts of cholesterol esters.</AbstractText>
            <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The congenital lipoid adrenal hyperplasia phenotype is the result of two separate events, an initial genetic loss of steroidogenesis that is dependent on steroidogenic acute regulatory protein and a subsequent loss of steroidogenesis that is independent of the protein due to cellular damage from accumulated cholesterol esters.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
            <Author ValidYN="Y">
                <LastName>Bose</LastName>
                <ForeName>H S</ForeName>
                <Initials>HS</Initials>
                <AffiliationInfo>
                    <Affiliation>Department of Pediatrics, University of California at San Francisco, 94143-0978, USA.</Affiliation>
                </AffiliationInfo>
            </Author>
            <Author ValidYN="Y">
                <LastName>Sugawara</LastName>
                <ForeName>T</ForeName>
                <Initials>T</Initials>
            </Author>
            <Author ValidYN="Y">
                <LastName>Strauss</LastName>
                <ForeName>J F</ForeName>
                <Initials>JF</Initials>
                <Suffix>3rd</Suffix>
            </Author>
            <Author ValidYN="Y">
                <LastName>Miller</LastName>
                <ForeName>W L</ForeName>
                <Initials>WL</Initials>
            </Author>
            <Author ValidYN="Y">
                <CollectiveName Investigators="group-1-8948562.1">International Congenital Lipoid Adrenal Hyperplasia Consortium</CollectiveName>
            </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
            <Grant>
                <GrantID>DK37922</GrantID>
                <Acronym>DK</Acronym>
                <Agency>NIDDK NIH HHS</Agency>
                
            </Grant>
            <Grant>
                <GrantID>DK42154</GrantID>
                <Acronym>DK</Acronym>
                <Agency>NIDDK NIH HHS</Agency>
                
            </Grant>
        </GrantList>
        <PublicationTypeList>
            <PublicationType UI="D016428">Journal Article</PublicationType>
            <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
            <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
    </Article>
    <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>N Engl J Med</MedlineTA>
        <NlmUniqueID>0255562</NlmUniqueID>
        <ISSNLinking>0028-4793</ISSNLinking>
    </MedlineJournalInfo>
    <ChemicalList>
        <Chemical>
            <RegistryNumber>0</RegistryNumber>
            <NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance>
        </Chemical>
        <Chemical>
            <RegistryNumber>0</RegistryNumber>
            <NameOfSubstance UI="C090395">steroidogenic acute regulatory protein</NameOfSubstance>
        </Chemical>
    </ChemicalList>
    <CitationSubset>IM</CitationSubset>
    <MeshHeadingList>
        <MeshHeading>
            <DescriptorName UI="D000311" MajorTopicYN="N">Adrenal Glands</DescriptorName>
            <QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
            <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D000312" MajorTopicYN="N">Adrenal Hyperplasia, Congenital</DescriptorName>
            <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
            <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
            <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D016368" MajorTopicYN="N">Frameshift Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D005820" MajorTopicYN="N">Genetic Testing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
            <DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName>
            <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
    </MeshHeadingList>
    <InvestigatorList ID="group-1-8948562.1">
        <Investigator ValidYN="Y">
            <LastName>Fujieda</LastName>
            <ForeName>K</ForeName>
            <Initials>K</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Ben-Neriah</LastName>
            <ForeName>Z</ForeName>
            <Initials>Z</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>R√∂sler</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>M√ºller</LastName>
            <ForeName>J</ForeName>
            <Initials>J</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Schwartz</LastName>
            <ForeName>M</ForeName>
            <Initials>M</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Skakkebaeck</LastName>
            <ForeName>N E</ForeName>
            <Initials>NE</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Nawas</LastName>
            <ForeName>M N</ForeName>
            <Initials>MN</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Papadimitriou</LastName>
            <ForeName>A</ForeName>
            <Initials>A</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Winter</LastName>
            <ForeName>J S</ForeName>
            <Initials>JS</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Cowell</LastName>
            <ForeName>C T</ForeName>
            <Initials>CT</Initials>
        </Investigator>
        <Investigator ValidYN="Y">
            <LastName>Warne</LastName>
            <ForeName>G</ForeName>
            <Initials>G</Initials>
        </Investigator>
    </InvestigatorList>
</MedlineCitation>
<PubmedData>
    <History>
        <PubMedPubDate PubStatus="pubmed">
            <Year>1996</Year>
            <Month>12</Month>
            <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
            <Year>2001</Year>
            <Month>3</Month>
            <Day>28</Day>
            <Hour>10</Hour>
            <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
            <Year>1996</Year>
            <Month>12</Month>
            <Day>19</Day>
            <Hour>0</Hour>
            <Minute>0</Minute>
        </PubMedPubDate>
    </History>
    <PublicationStatus>ppublish</PublicationStatus>
    <ArticleIdList>
        <ArticleId IdType="pubmed">8948562</ArticleId>
        <ArticleId IdType="doi">10.1056/NEJM199612193352503</ArticleId>
    </ArticleIdList>
</PubmedData>
</PubmedArticle>
</PubmedArticleSet>